18
Participants
Start Date
August 31, 2014
Primary Completion Date
December 31, 2021
Study Completion Date
December 31, 2021
Bone marrow transplant
Day 0
Thymoglobulin
0.5 mg/kg IV on Day -9 2 mg/kg IV on Days -8, -7
Fludarabine
30 mg/M2 IV on days -6 to -2
Cyclophosphamide
14.5 mg/kg IV on days -6, -5, 3, 4
TBI
200 cGy on day -1
Mesna
40 mg/kg IV on days 3, 4
Tacrolimus
For patients 18 years or older, tacrolimus will be given per institutional standards; may be increased or later changed to a PO BID schedule. Treatment to continue until Day 365 or longer if GVHD present
Mycophenolic acid mofetil
15 mg/kg PO/IV TID beginning on day 5 through day 35
The Sidney Kimmel Comprehensive Cancer Center, Baltimore
Medical College of Wisconsin/Children's Hospital of Wisconsin, Milwaukee
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OTHER